CDC: Proposed Data Collection Submitted for Public Comment and Recommendations
The Centers for Disease Control and Prevention (CDC) is seeking comments on a proposed information collection project titled "Formative Research and Tool Development." This information collection request is designed to allow CDC's National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) to conduct formative research information collection activities used to inform many aspects of surveillance, communications, health promotion, and research project development for NCHHSTP's four priority diseases: HIV/AIDS, sexually transmitted diseases/infections (STD/STI), viral hepatitis, tuberculosis elimination (TB), ...
Source: Federal Register updates via the Rural Assistance Center - September 26, 2023 Category: Rural Health Source Type: news
Dynamic Risk Assessment for HCC in Patients With Chronic HCV Dynamic Risk Assessment for HCC in Patients With Chronic HCV
The authors developed a model for identifying hepatocellular carcinoma risk factors in individuals with chronic HCV, across antiviral treatment status and interactions with cirrhosis.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 20, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Advancing care for people with HIV and hepatitis C
A set of studies co-authored by Yale researchers seeks to address racial disparities in access to treatment for people living with both hepatitis C and HIV. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 18, 2023 Category: Universities & Medical Training Source Type: news
Addressing disparities in HIV and hepatitis C care
A set of studies co-authored by Yale researchers seeks to address racial disparities in access to treatment for people living with both hepatitis C and HIV. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 18, 2023 Category: Universities & Medical Training Source Type: news
Revaccination Suggested for Hep B Vaccine Nonresponders After Hep C Cure
MONDAY, Sept. 18, 2023 -- Patients with chronic hepatitis C virus (HCV) who do not respond to hepatitis B virus (HBV) vaccine should undergo revaccination after HCV treatment and eradication, according to a study published online July 31 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news
Cost-effectiveness of Treating All HBV+ Individuals in the U.S. Cost-effectiveness of Treating All HBV+ Individuals in the U.S.
This analysis suggests that expanding efforts to diagnose and treat individuals chronically infected with HBV would be cost-effective and provide a positive return on investment.Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - September 13, 2023 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
People Infected With Hepatitis C May Need the Hepatitis B Shot
MONDAY, Sept. 11, 2023 -- Patients with hepatitis C should consider being vaccinated again for hepatitis B, because their immune response to the initial shot may be inadequate, a new study suggests.
Researchers at the University of Minnesota Medical... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 11, 2023 Category: General Medicine Source Type: news
HRSA: Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
The Centers for Disease Control and Prevention (CDC) and Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) will hold a hybrid public meeting on October 24-25, 2023. Agenda items include discussions related to HIV and Hepatitis C co-infection, payment models for addressing social determinants of health, incorporating stigma reduction in HIV care and treatment, as well as other special presentations.Registration is required. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - September 11, 2023 Category: Rural Health Source Type: news
Hepatitis C Virus Clearance Cascade, U.S. 2013-2022 Hepatitis C Virus Clearance Cascade, U.S. 2013-2022
This analysis of the HCV clearance cascade using 2013-2022 national HCV testing data found a lower than targeted viral clearance rate, especially among the young, uninsured or underinsured.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 8, 2023 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news
Hepatitis C Virus Still Leading Cause of Hepatocellular Cancer in Men
THURSDAY, Sept. 7, 2023 -- The leading cause of hepatocellular carcinoma (HCC) is still hepatitis C virus (HCV) among men, but the rates of HCV-HCC have decreased since 2015, according to a study published online Sept. 5 in Clinical Gastroenterology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 7, 2023 Category: Pharmaceuticals Source Type: news
Nurse Accused of Spreading Hep C Takes Plea Deal; Army Doc's Alleged Sexual Assault
(MedPage Today) -- Cora Weberg, the former Washington state nurse who was accused of infecting 12 patients with hepatitis C, took a plea deal that comes with a prison sentence of up to 10 years and a maximum fine of $250,000. (KIRO 7)
California... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 7, 2023 Category: American Health Source Type: news
SOF/VEL in Patients Aged 6-18 Years With Chronic HCV SOF/VEL in Patients Aged 6-18 Years With Chronic HCV
This real-world study found sofosbuvir/velpatasvir 100% effective in a pediatric population with chronic hepatitis C, with no serious adverse effects.Liver International (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - September 6, 2023 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
The Danger of ‘Invisible’ Biolabs Across the U.S.
Recently, many California residents were disturbed to learn that a small, privately-operated bio lab in the Central Valley town of Reedley was shut down by Fresno County Department of Public Health officials after they found that it had been improperly managing almost 1,000 laboratory mice and samples of infectious diseases including COVID-19, rubella, malaria, dengue, chlamydia, hepatitis, and HIV. The lab was registered to a company called Prestige Biotech that sold a variety of medical testing kits, including for pregnancy and COVID-19, and it was likely storing disease samples for the purpose of developing and validati...
Source: TIME: Health - August 31, 2023 Category: Consumer Health News Authors: Dan Greene, Jassi Pannu and Allison Berke Tags: Uncategorized Science Source Type: news
Experts warn of Hepatitis risk from foreign health and dental treatments
Thousands of people may have undiagnosed hepatitis C caught abroad during tattoos, piercings or medical procedures, experts warn. (Source: Daily Express - Health)
Source: Daily Express - Health - August 30, 2023 Category: Consumer Health News Source Type: news
Mortality Rates Remain High After Hepatitis C Cure Mortality Rates Remain High After Hepatitis C Cure
Mortality rates remain substantially elevated after successful treatment of hepatitis C infection in the era of interferon-free antiviral therapy, a study of over 20,000 patients has found.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 22, 2023 Category: Gastroenterology Tags: Gastroenterology Source Type: news
